CIK 0001579428
- Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454241907
- Phone
- +1 212-332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-22 | Pizzie Nick Chief Financial Officer | Sale 10b5-1 | −12,000 | $187.92 | $2.3M | 42,588 |
| 2026-01-21 | Maizel Ari Chief Commercial Officer | Sale 10b5-1 | −7,500 | $184.44 | $1.4M | 0 |
| 2026-01-07 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −31,261 | $170.38 | $5.3M | 7,229 |
| 2026-01-06 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −29,450 | $172.33 | $5.1M | 7,229 |
| 2026-01-05 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −78,703 | $171.28 | $13.5M | 7,229 |
| 2025-12-31 | Saad Mark E Director | Sale 10b5-1 | −6,231 | $165.18 | $1.0M | 10,002 |
| 2025-12-31 | Saad Mark E Director | Sale 10b5-1 | −31,346 | $165.18 | $5.2M | 10,002 |
| 2025-12-04 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −10,558 | $148.18 | $1.6M | 7,229 |
| 2025-12-03 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −20,163 | $146.94 | $3.0M | 7,229 |
| 2025-12-02 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −49,252 | $144.59 | $7.1M | 7,229 |
| 2025-11-05 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −21,775 | $134.49 | $2.9M | 7,229 |
| 2025-11-04 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −50,459 | $133.79 | $6.8M | 7,229 |
| 2025-11-03 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −91,705 | $132.34 | $12.1M | 7,229 |
| 2025-10-08 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −12,774 | $118.84 | $1.5M | 7,229 |
| 2025-10-07 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −13,390 | $118.77 | $1.6M | 7,229 |
| 2025-10-06 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −19,220 | $120.17 | $2.3M | 7,229 |
| 2025-09-22 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −10,000 | $115.96 | $1.2M | 0 |
| 2025-09-16 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −5,783 | $116.19 | $672K | 0 |
| 2025-09-16 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −40,000 | $114.23 | $4.6M | 0 |
| 2025-09-16 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −19,719 | $114.19 | $2.3M | 7,229 |
Page 2 of 4 · 73 trades